Comment from Empower Pharmacy
AnonymousSupportBusiness
Summary: Empower Pharmacy is requesting to amend its nomination for L-Citrulline on the 503B Bulks Substance List. They seek to retract specific proposed uses and replace them with new indications for the management of hyperammonaemia and postoperative pulmonary hypertension.
See attached file(s)